Optimising Kidney Utilisation 2022
Life Sciences & Medicine
Continuing Professional Development (CPD)
Not for credit
Available course dates:
To be confirmed
Decisions on whether to accept or decline a deceased donor kidney transplant offer, and who best to implant an organ into, are challenging and complex. This course aims to provide a framework and evidence-base on how to approach these decisions. The course has been re-designed for 2022 and will now include a dedicated breakout session for nurses. There will also be a focus on emerging issues within kidney utilisation, such as the use of organs from SARS-CoV-2 positive deceased donors.
The course will be hosted by clinicians from Guy’s & St Thomas’ NHS Foundation Trust (GSTT): Mr Chris Callaghan (consultant transplant surgeon), Mr Jonathon Olsburgh (consultant transplant surgeon) and Dr Rachel Hilton (consultant nephrologist). They will be joined by consultants and senior nursing colleagues from across the UK, and the US.
What does this course cover?
The course will emphasise:
- A progressive approach to organ utilisation, based on extensive clinical experience.
- Close collaboration between surgeons, nephrologists, other professionals involved in the donation and implantation pathway, and patients.
- An evidence-based approach to deceased donor kidney utilisation, and best practice in recipient consent.
What will I achieve?
By the end of the course you will be able to:
- Understand the context of UK deceased donor kidney transplantation.
- Understand the national organ offering schemes in the UK.
- Understand the evidence base for the use of increased risk organs.
- Develop a framework for approaching complex organ utilisation decisions in deceased donor kidney transplantation.
- CPD accreditation for this programme is in progress
Who will I learn with?
Consultant Transplant Surgeon
Consultant Urologist and Transplant Surgeon
Nephrology Trainee currently working as a Clinical Research Fellow for NHSBT
Member of the Department of Health Safety of Blood Tissues and Organs Advisory Committee and of the Data Monitoring Committee of the NHSBT Clinical Trials Unit
Clinical research fellow at NHS Blood and Transplant
Consultant Clinical Virologist at NHS Blood and Transplant
Director of Solid Organ Transplant Infectious Disease and Associate Professor of Internal Medicine in the Division of Infectious Diseases and Geographic Medicine at UT Southwestern Medical Centers.
Professor of Transplantation in Cambridge, former BTS president and co-chair of the Donor Organ Risk Assessment subgroup of SABTO
consultant transplant and urological surgeon at Guy's Hospital, London
Consultant transplant, organ retrieval and general surgeon at St James's Hospital, Leeds
Professor of Clinical and Experimental Transplantation at the University of Cambridge
Lead Clinical Nurse Specialist
Lead Nurse for Renal Transplantation, Viral Hepatitis and NORS at Leeds Teaching Hospitals
Kidney Transplant Coordinator at Guy’s Hospital in London
transplant and dialysis access surgeon at Guy’s Hospital
Principal Statistician within the Statistics and Clinical Studies team at NHS Blood and Transplant (NHSBT)
Consultant Renal Transplant Physician at Leeds Teaching Hospitals NHS Trust
Who is this for?
This course will be most appropriate for:
- Senior transplant surgery or nephrology trainees
- Recently appointed consultant transplant surgeons or nephrologists
- Recipient transplant coordinators
- Specialist nurses in organ donation (SNODs)
- Established consultant nephrologists or renal transplant surgeons looking for an update in organ utilisation issues
- Senior nurses involved in caring for potential patients on the deceased donor kidney transplant waiting list and post-transplant kidney recipients
What is the teaching schedule?
Session 1: Plenary – Over-arching issues in deceased donor kidney transplantation
Session 2: Plenary – Emerging issues in deceased donor kidney transplantation
Break-out room 1: Surgeons and nephrologists
Break-out room 2: RTCs and nursing colleagues
Session 4: Case-based discussions, consent and risk